PTHS

Pelthos Therapeutics Inc.

Healthcare · Biotechnology

$188.50 sample

+1.58 (+0.85%) 1D

Market cap

$544.1B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-04

Alerts

8

Price$188.50 +18.90% 3M daily closessample

193.40158.54

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: Chief Financial Officer
Sep 22INSInsider sell: Director
Sep 17INSInsider sell: EVP, Operations
Sep 09INSInsider buy: EVP, Operations
Aug 31INSInsider sell: Chief Executive Officer
Aug 20INSInsider sell: Chief Executive Officer
Aug 11INSInsider sell: General Counsel
Aug 04SEC8-K filed: material event

Sign up to see the real PTHS record →

Company facts

SEC EDGAR registration

Name: Pelthos Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +19sample, -100 to +100
Reporting currency: USD

Who is positioning in PTHS

sample

Insiders: 6 insider transactions over 90 days, net selling, $8.2M
Congress: No member trades over 90 days
Institutions · 13F: 18 funds hold $3.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.2B +14.0% y/y

Q4 2024Q3 2026

Inventory$14.2B +12.2% y/y

Q4 2024Q3 2026

Accounts receivable$10.2B +13.1% y/y

Q4 2024Q3 2026

Total debt$27.9B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $231.0B -7.4% 3M
Sample peer B: $377.9B -7.9% 3M
Sample peer C: $315.3B +10.2% 3M
Sample peer D: $144.3B +15.7% 3M
Sample peer E: $306.0B -0.7% 3M